Chapel Hill-based pharmaceutical company raises $200,000
A Chapel Hill-based pharmaceuticals company raised $200,000 from one investor, according to a filing with the Securities and Exchange Commission. AimMax Therapeutics Inc. filed the Form D on April 17. The first sale occurred on April 14. According to the filing, the company does not intend the offering to last more than one year, and it is not being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer. Founded in 2016, the company aims to research and develop pharmaceuticals and therapeutics for the treatment and prevention of diseases. The company claimed a...
Read More